Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).
Farr A, Effendy I, Frey Tirri B, Hof H, Mayser P, Petricevic L, Ruhnke M, Schaller M, Schaefer APA, Sustr V, Willinger B, Mendling W.
Mycoses. 2021 Jun;64(6):583-602. doi: 10.1111/myc.13248. Epub 2021 Feb 27.
Low-dose oral misoprostol for induction of labour.
Kerr RS, Kumar N, Williams MJ, Cuthbert A, Aflaifel N, Haas DM, Weeks AD.
Cochrane Database Syst Rev. 2021 Jun 22;6(6):CD014484. doi: 10.1002/14651858.CD014484.
Probiotics.
Mizock BA.
Dis Mon. 2015 Jul;61(7):259-90. doi: 10.1016/j.disamonth.2015.03.011. Epub 2015 Apr 25.
Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections.
Martens MG, Maximos B, Degenhardt T, Person K, Curelop S, Ghannoum M, Flynt A, Brand SR.
Am J Obstet Gynecol. 2022 Dec;227(6):880.e1-880.e11. doi: 10.1016/j.ajog.2022.07.023. Epub 2022 Jul 19.
Vaginal delivery among women who underwent labor induction with vaginal dinoprostone (PGE2) insert: a retrospective study of 1656 women in China.
Zhao L, Lin Y, Jiang TT, Wang L, Li M, Wang Y, Sun GQ, Xiao M.
J Matern Fetal Neonatal Med. 2019 May;32(10):1721-1727. doi: 10.1080/14767058.2017.1416351. Epub 2017 Dec 21.
Effect of vaginal pH on efficacy of dinoprostone gel for labour induction: a cross-sectional study.
Poomalar GK, Fathima Shantini N, Ezhil R.
J Obstet Gynaecol. 2022 Feb;42(2):228-231. doi: 10.1080/01443615.2021.1904225. Epub 2021 May 21.
Randomised clinical trial in women with Recurrent Vulvovaginal Candidiasis: Efficacy of probiotics and lactoferrin as maintenance treatment.
Russo R, Superti F, Karadja E, De Seta F.
Mycoses. 2019 Apr;62(4):328-335. doi: 10.1111/myc.12883. Epub 2019 Feb 20.
Comparison of the effect of oral and vaginal misoprostol on labor induction: updating a systematic review and meta-analysis of interventional studies.
Rahimi M, Haghighi L, Baradaran HR, Azami M, Larijani SS, Kazemzadeh P, Moradi Y.
Eur J Med Res. 2023 Jan 27;28(1):51. doi: 10.1186/s40001-023-01007-8.
Misoprostol vaginal insert for induction of labor: a delivery system with accurate dosing and rapid discontinuation.
Stephenson ML, Hawkins JS, Powers BL, Wing DA.
Womens Health (Lond). 2014 Jan;10(1):29-36. doi: 10.2217/whe.13.49.
Efficacy and safety of oral and vaginal administration of misoprostol for induction of labor in high-risk obese pregnant women with hypertension or diabetes mellitus.
Tian S, Wang L, Han YW, Liu YN, Li FQ, Jin XH.
J Matern Fetal Neonatal Med. 2024 Dec;37(1):2327573. doi: 10.1080/14767058.2024.2327573. Epub 2024 Mar 14.
